https://www.has-sante.fr/jcms/p_3259937/fr/selincro 2021 false false false France French evaluation of the transparency committee treatment outcome insurance, health, reimbursement nalmefene hydrochloride administration, oral adult alcoholism alcohol drinking nalmefene nalmefene naltrexone naltrexone
--- https://www.has-sante.fr/jcms/c_2872648/fr/selincro 2018 false false false false France French evaluation of the transparency committee nalmefene hydrochloride nalmefene nalmefene naltrexone naltrexone
--- http://www.has-sante.fr/jcms/c_1716023/fr/selincro 2014 false false false France French English evaluation of the transparency committee administration, oral treatment outcome insurance, health, reimbursement nalmefene hydrochloride nalmefene hydrochloride nalmefene nalmefene nalmefene narcotic antagonists narcotic antagonists alcohol drinking adult alcoholism guidelines for drug use naltrexone naltrexone naltrexone
--- https://www.ema.europa.eu/medicines/human/EPAR/Selincro 2013 false United Kingdom French English nalmefene nalmefene drug approval treatment outcome administration, oral nalmefene hydrochloride nalmefene hydrochloride summary of product characteristics package leaflet drug evaluation syndication feed alcoholism adult naltrexone social support narcotic antagonists narcotic antagonists randomized controlled trials as topic alcohol drinking drug evaluation, preclinical drug interactions pregnancy breast feeding Nalmefene hydrochloride (product) nalmefene
Currated CISMeF NLP mapping